These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12618054)

  • 1. Familial and sporadic Parkinson's disease usually display the same clinical features.
    Carr J; de la Fuente-Fernández R; Schulzer M; Mak E; Calne SM; Calne DB
    Parkinsonism Relat Disord; 2003 Mar; 9(4):201-4. PubMed ID: 12618054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic analysis of the alpha-synuclein and the parkin gene in Parkinson's disease in Finland.
    Autere JM; Hiltunen MJ; Mannermaa AJ; Jäkälä PA; Hartikainen PH; Majamaa K; Alafuzoff I; Soininen HS
    Eur J Neurol; 2002 Sep; 9(5):479-83. PubMed ID: 12220378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.
    Hattori N; Shimura H; Kubo S; Wang M; Shimizu N; Tanaka K; Mizuno Y
    J Neural Transm Suppl; 2000; (60):101-16. PubMed ID: 11205133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Parkinson's disease. Alpha-synuclein and parkin.
    Mizuno Y; Hattori N; Kitada T; Matsumine H; Mori H; Shimura H; Kubo S; Kobayashi H; Asakawa S; Minoshima S; Shimizu N
    Adv Neurol; 2001; 86():13-21. PubMed ID: 11553970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of Parkinson's disease.
    Gasser T
    J Neurol; 2001 Oct; 248(10):833-40. PubMed ID: 11697518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A 73-year-old woman with familial Parkinson's disease].
    Takanashi M; Urabe T; Ohta S; Hamano Y; Mori H; Shirai T; Kondo T; Mizuno Y
    No To Shinkei; 1999 Dec; 51(12):1087-96. PubMed ID: 10654309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of parkinsonism.
    Gwinn-Hardy K
    Mov Disord; 2002 Jul; 17(4):645-56. PubMed ID: 12210852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in familial Parkinson's disease.
    Mizuno Y; Hattori N; Yoshino H; Hatano Y; Satoh K; Tomiyama H; Li Y
    J Neural Transm Suppl; 2006; (70):191-204. PubMed ID: 17017529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease: one biochemical pathway to fit all genes?
    Krüger R; Eberhardt O; Riess O; Schulz JB
    Trends Mol Med; 2002 May; 8(5):236-40. PubMed ID: 12067634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Synuclein and parkin: coming together of pieces in puzzle of Parkinson's disease.
    Burke RE
    Lancet; 2001 Nov; 358(9293):1567-8. PubMed ID: 11716878
    [No Abstract]   [Full Text] [Related]  

  • 12. The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects.
    Lim KL; Dawson VL; Dawson TM
    Ann N Y Acad Sci; 2003 Jun; 991():80-92. PubMed ID: 12846976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetics and environmental factors of Parkinson disease].
    Broussolle E; Thobois S
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Parkinson's disease.
    Mizuno Y; Hattori N; Mori H
    Biomed Pharmacother; 1999 Apr; 53(3):109-16. PubMed ID: 10349506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular biology for familial Parkinson's disease].
    Shiba K; Hattori N
    Nihon Rinsho; 2004 Sep; 62(9):1617-22. PubMed ID: 15462374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the clinical and molecular genetics of familial parkinsonism.
    Kitada T; Asakawa S; Matsumine H; Hattori N; Shimura H; Minoshima S; Shimizu N; Mizuno Y
    Neurogenetics; 2000 Mar; 2(4):207-18. PubMed ID: 10983716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
    McNaught KS; Olanow CW
    Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease.
    Papapetropoulos S; Paschalis C; Athanassiadou A; Papadimitriou A; Ellul J; Polymeropoulos MH; Papapetropoulos T
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):662-5. PubMed ID: 11309462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.